A Mn Al double adjuvant nanovaccine to induce strong humoral and cellular immune responses
Nan Qiao,Hairui Wang,Yanhua Xu,Yu Chang,Mingxin Xie,Shuting Bai,Chunting He,Ming Qin,Xiaofang Zhong,Min Jiang,Zhaofei Guo,Guangsheng Du,Zhirong Zhang,Yuandong Zhang,Xun Sun
DOI: https://doi.org/10.1016/j.jconrel.2023.04.036
IF: 11.467
2023-05-06
Journal of Controlled Release
Abstract:At present, the most widely used aluminum adjuvants have poor ability to induce effective Th1 type immune responses. Existing evidence suggests that manganese is a potential metal adjuvant by activating cyclic guanosine phospho-adenosine synthase (cGAS)-interferon gene stimulator protein (STING) signaling pathway to enhance humoral and cellular immune response. Hence, the effective modulation of metal components is expected to be a new strategy to improve the efficiency of vaccine immunization. Here, we constructed a manganese and aluminum dual-adjuvant antigen co-delivery system (MnO 2 -Al-OVA) to enhance the immune responses of subunit vaccines . Namely, the aluminum hydroxide was first fused on the surface of the pre-prepared MnO 2 nanoparticles , which were synthesized by a simple redox reaction with potassium permanganate (KMnO 4 ) and oleic acid (OA). The engineered MnO 2 -Al-OVA could remarkably promote cellular internalization and maturation of dendritic cells. After subcutaneous vaccination, MnO 2 -Al-OVA rapidly migrated into the lymph nodes (LNs) and efficiently activate the cGAS-STING pathway, greatly induced humoral and cellular immune responses. Of note, our findings underscore the importance of coordination manganese adjuvants in vaccine design by promoting the activation of the cGAS-STING-IFN-I pathway. With a good safety profile and facile preparation process, this dual-adjuvant antigen co-delivery nanovaccine has great potential for clinical translation prospects.
pharmacology & pharmacy,chemistry, multidisciplinary